Septic shock in obstetrics.
Septic shock in obstetric patients can be prevented by recognition of patients at risk and aggressive intervention in the warm-hypotensive phase. These patients must be monitored closely. Rarely will an obstetrical floor be capable of providing adequate monitoring of these patients; therefore, the patient should be transferred to an intensive care unit. Individualize therapy, but do not procrastinate in the surgical removal of the nidus of infection.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D004211:Disseminated Intravascular Coagulation / Q000209:etiology; D004298:Dopamine / Q000627:therapeutic use; D004630:Emergencies; D004731:Endotoxins / Q000494:pharmacology; D005260:Female; D006801:Humans; D007362:Intensive Care Units; D007668:Kidney / Q000503:physiopathology; D008099:Liver / Q000503:physiopathology; D008168:Lung / Q000503:physiopathology; D009270:Naloxone / Q000627:therapeutic use; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000503:physiopathology / Q000628:therapy; D011453:Prostaglandins / Q000378:metabolism; D012772:Shock, Septic / Q000503:physiopathology / Q000628:therapy
D000900:Anti-Bacterial Agents; D004731:Endotoxins; D011453:Prostaglandins; D009270:Naloxone; D001241:Aspirin; D004298:Dopamine